Alarmed by rising prescription drug prices, Massachusetts officials are seeking permission from the federal government to limit the number of medicines that would be covered by the state Medicaid program, which is currently required to provide coverage for all treatments.
In making their request, state officials argue they should be able to use some of the same tools that commercial insurers employ to contain costs. And they insist such a move is needed in order to preserve the larger mission of providing adequate health coverage.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTEDWhat is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
About the Author Reprints
Great write-up, I’m regular visitor of one’s website, maintain up the excellent operate, and It is going to be a regular visitor for a lengthy time.
wretye5ryabcd.com